Page last updated: 2024-09-04
docetaxel anhydrous and Sublingual Gland Neoplasms
docetaxel anhydrous has been researched along with Sublingual Gland Neoplasms in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Hatayama, Y; Kakehata, S; Maruya, S; Matsubara, A; Nagahata, M; Namba, A; Shinkawa, H; Shirasaki, T; Takeda, I; Yokoyama, J | 1 |
Other Studies
1 other study(ies) available for docetaxel anhydrous and Sublingual Gland Neoplasms
Article | Year |
---|---|
Salivary gland carcinoma treated with concomitant chemoradiation with intraarterial cisplatin and docetaxel.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Parotid Neoplasms; Radiotherapy, Adjuvant; Sublingual Gland Neoplasms; Taxoids; Treatment Outcome | 2006 |